Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Vascular endothelial growth fa...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Vascular endothelial growth factor (VEGF) fails to predict response to neoadjuvant chemotherapy for primary breast cancer.
Bibliographic Details
Main Authors:
Burcombe, R
,
Makris, A
,
Davies, C
,
Cladd, H
,
Wilson, G
,
Harris, A
Format:
Conference item
Published:
2002
Holdings
Description
Similar Items
Staff View
Similar Items
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
by: Tolaney, Sara M., et al.
Published: (2017)
Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
by: Lim, L.Y., et al.
Published: (2016)
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
by: Abraham, JE, et al.
Published: (2024)
Serum vascular endothelial growth factor (vegf) as a biomarker of lupus nephritis
by: Iberahim, Rahimah
Published: (2013)
Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy
by: Ngidi, S, et al.
Published: (2017)